Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase

References

• Aasted B. Purification and characterization of human vascular plasminogen activator. Biochim. Biophys. Acta 1980; 621: 241
   PubMed Web of Science ®Google Scholar
• Aoki N. Preparation of plasminogen activator from vascular tree of human cadavers. J. Biochem. 1974; 75: 731
   PubMed Web of Science ®Google Scholar
• Aoki N., von Kaulla K. N. The extraction of vascular plasminogen activator from human cadavers and a description of some of its properties. Am. J. clin. Path. 1971; 55: 171
   PubMed Web of Science ®Google Scholar
• Åstedt B. No crossreaction between circulating plasminogen activator and urokinase. Thromb. Res. 1979; 14: 535
   PubMed Web of Science ®Google Scholar
• Åstedt B., Barlow G., Holmberg L. Time-related release of various molecular forms of urokinase in tissue culture. Thromb. Res. 1977; 11: 149
   PubMed Web of Science ®Google Scholar
• Åstedt B., Holmberg L. Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature 1976; 261: 595
   PubMed Web of Science ®Google Scholar
• Åstedt B., Holmberg L., Lecander I., Thorell J. Radioimmunoassay of urokinase for quantification of plasminogen activators released in ovarian tumour cultures. Eur. J. Cancer 1981; 17: 239
   PubMed Web of Science ®Google Scholar
• Åstedt B., Pandolfi M. Ontogenesis of tissue plasminogen activator in the human. Thromb. Diath. Haemorrh. 1971; 25: 469
   PubMedGoogle Scholar
• Åstedt B., Pandolfi M., Nilsson I. M. Inhibitory effect of placenta on plasminogen activation in human organ culture. Proc. Soc. exp. Biol. Med. 1972; 139: 1421
   PubMed Web of Science ®Google Scholar
• Åstedt B., Wallén P., Aasted B. Occurrence of both urokinase and tissue plasminogen activator in human seminal plasma. Thromb. Res. 1979; 16: 463
   PubMed Web of Science ®Google Scholar
• Astrup T. Fibrinolysis: An overview. Progress in Chemical Fibrinolysis and Thrombolysis, J. F. Davidson, R. M. Rowman, M. M. Samama, P. C. Desnoyers. Raven Press, New York 1978; Vol. 3: 1
   Google Scholar
• Astrup T., Albrechtsen O. K. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scand. J. clin. Lab. Invest. 1957; 9: 233
   PubMed Web of Science ®Google Scholar
• Astrup T., Henrichsen J., Tympanidis K., King A. E. Fibrinolytically active vaginal epithelial cells. Nature 1967; 214: 297
   PubMed Web of Science ®Google Scholar
• Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. Biophys. 1952; 40: 346
   PubMed Web of Science ®Google Scholar
• Astrup T., Permin P. M. Fibrinolysis in the animal organism. Nature 1947; 159: 681
   PubMed Web of Science ®Google Scholar
• Astrup T., Sterndorff I. An activator of plasminogen in normal urine. Proc. Soc. exp. Biol. Med. 1952; 81: 675
   PubMed Web of Science ®Google Scholar
• Bachmann F., Fletcher A. P., Alkjaersig N., Sherry S. Partial purification and properties of the plasminogen activator from pig heart. Biochemistry 1964; 3: 1578
   PubMed Web of Science ®Google Scholar
• Barlow G. H., Lazer L. V. Characterization of the plasminogen activator isolated from human embryo kidney cells: comparison with urokinase. Thromb. Res. 1972; 1: 201
   Google Scholar
• Bigbee W. L., Jensen R. H. Characterization of plasminogen activator in human cervical cells. Biochem. Biophys. Acta. 1978; 540: 285
   PubMed Web of Science ®Google Scholar
• Binder B. R., Spragg J., Austen K. F. Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates. J. biol. Chem. 1979; 254: 1998
   PubMed Web of Science ®Google Scholar
• Casslén B. Proteinases and proteinase inhibitors in uterine fluid with special reference to IUD-users. Acta obstet. gynecol. scand. 1981, Suppl. 98: 18
   Google Scholar
• Dosne A. M., Dupuy E., Bodevin E. Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein. Thromb. Res. 1978; 12: 377
   PubMed Web of Science ®Google Scholar
• Holmberg L., Bladh B., Astedt B. Purification of urokinase by affinity chromatography. Biochem. Biophys. Acta 1976; 445: 215
   PubMed Web of Science ®Google Scholar
• Holmberg L., Lecander I., Persson B., Åstedt B. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim. Biophys. Acta 1978; 544: 128
   PubMed Web of Science ®Google Scholar
• Holmberg L., Nilsson I. M., Wallén P., Åstedt B. Studies on the blood plasminogen activator induced by 1-desamino-8-D-arginine-vasopressin with observations in von Willebrand's disease. Proc. Soc. exp. Biol. Med., in press
   Google Scholar
• Kok P., Astrup T. Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Biochemistry 1969; 8: 79
   PubMed Web of Science ®Google Scholar
• Levin E. G., Loskutoff D. J. Comparative studies of the fibrinolytic activity of cultured vascular cells. Thromb. Res. 1979; 15: 869
   PubMed Web of Science ®Google Scholar
• Loskutoff D. J., Edgington T. S. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc. natn. Acad. Sci. 1977; 74: 3903
   PubMed Web of Science ®Google Scholar
• Loskutoff D. J., Edgington T. S. An inhibitor of plasminogen activator in rabbit endothelial cells. J. biol. Chem. 1981; 256: 4142
   PubMed Web of Science ®Google Scholar
• Nagy B., Ban J., Brdar B. Fibrinolysis associated with human neoplasia: production of plasminogen activator by human tumours. Int. J. Cancer 1977; 19: 614
   PubMed Web of Science ®Google Scholar
• Pandolfi M., Astrup T. A histochemical study of the fibrinolytic activity. Cornea, conjunctiva and lacrimal gland. Arch. Ophtalmol. 1967; 77: 258
   PubMedGoogle Scholar
• Ploug J., Kjeldgaard N. O. Urokinase. An activator of plasminogen from human urine. Biochim. Biophys. Acta 1957; 24: 278
   PubMed Web of Science ®Google Scholar
• Propping D., Zaneveld L. J.D., Tauber P. F., Schumacher G. F.B. Purification of plasminogen activators from human seminal plasma. Biochem. J. 1978; 171: 435
   PubMed Web of Science ®Google Scholar
• Rijken D. C., Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J. biol. Chem. 1981; 256: 7035
   PubMed Web of Science ®Google Scholar
• Rijken D. C., Wijngaards G., Welbergen J. Relationship between tissue plasminogen activator and the activators in blood and vascular wall. Thromb. Res. 1980; 18: 815
   PubMed Web of Science ®Google Scholar
• Rijken D. C., Wijngaards G., Welbergen J. Immunological characterization of plasminogen activator activities in human tissues and body fluids. J. Lab. clin. Med. 1981; 97: 477
   PubMed Web of Science ®Google Scholar
• Rijken D. C., Wijngaards G., Zaal-De Jong M., Welbergen J. Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim. Biophys. Acta 1979; 580: 140
   PubMed Web of Science ®Google Scholar
• Roblin R. O., Young P. L., Bell T. E. Concomitant secretion by transformed SVWI 38-VA 13–2RA cells of plasminogen activator(s) and substance(s) which prevent their detection. Biochem. Biophys. Res. Commun. 1978; 82: 165
   PubMed Web of Science ®Google Scholar
• Saito H., Ratnoff O. D., Donaldson V. H. Defective activation of clotting, fibrinolytic and permeability-enhancing systems in human Fletcher trait plasma. Circ. Res. 1974; 34: 641
   PubMed Web of Science ®Google Scholar
• Seifert S. C., Gelehrter T. D. Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells. Proc. natn. Acad. Sci. 1978; 75: 6130
   PubMed Web of Science ®Google Scholar
• Strickland S. E. Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell 1976; 9: 231
   PubMed Web of Science ®Google Scholar
• Thorell J. J., Johansson B. G. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim. Biophys. Acta 1971; 251: 363
   PubMed Web of Science ®Google Scholar
• Thorsen S., Glas-Greenwalt P., Astrup T. Difference in the binding to fibrin of urokinase and tissue plasminogen activator. Thromb. Diath. Haemorrh. 1972; 28: 65
   PubMedGoogle Scholar
• Todd A. S. Histological localization of fibrinolysin activator. J. Pathol. 1959; 78: 281
   Web of Science ®Google Scholar
• Tucker W. S., Kirsch W. M., Martinez-Hernandez A., Fink L. M. In vitro plasminogen activator activity in human brain tumours. Cancer Res. 1978; 38: 297
   PubMed Web of Science ®Google Scholar
• Vetterlein D., Bell T. E., Young P. L., Roblin R. Immunological quantitation and immunoabsorption of urokinase-like plasminogen activators secreted by human cells. J. biol. Chem. 1980; 255: 3665
   PubMed Web of Science ®Google Scholar
• Wallén P. Activation of plasminogen with urokinase and tissue activator. Thrombosis and Urokinase, R. Paoletti, S. Sherry. Academic Press, London, New York, San Francisco 1977; 91
   Google Scholar
• Wallén P., Rånby M., Bergsdorf N., Kok P. Purification and characterization of tissue plasminogen activator: on the occurrence of two different forms and their enzymatic properties. Progress in Fibrinolysis, J. F. Davidson, I. M. Nilsson, B. Åstedt. Churchill Livingstone, Edinburgh, London, Melbourne, New York 1981; Vol. 5: 16
   Google Scholar
• White W. F., Barlow G. H., Mozen M. M. The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 1966; 5: 2160
   PubMed Web of Science ®Google Scholar
• Wu M., Arimura G. K., Yunis A. A. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 1977; 16: 1908
   PubMed Web of Science ®Google Scholar